FIB
EGRX

First Interstate Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

First Interstate Bank’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-180
Closed -$14K – 728
2017
Q2 		$14K Buy
180
+65
+57% +$5.32K ﹤0.01% 512
2017
Q1 		$10K Buy
+115
New +$8.55K ﹤0.01% 551

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

First Interstate Bank's EGRX Position: Q3 2017 in Review

First Interstate Bank sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2017, closing a stake of 180 shares — an estimated $14K sold.

First Interstate Bank first reported a position in EGRX in Q1 2017 and held it in 2 quarters. The position peaked at $14K in Q2 2017. 169 funds tracked by Wall St. Rank hold EGRX as of Q3 2017.

  • First Interstate Bank reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • First Interstate Bank sold 180 Eagle Pharmaceuticals, Inc. shares in Q3 2017, an estimated $14K.
  • First Interstate Bank first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2017 and held it in 2 quarters.
  • First Interstate Bank's Eagle Pharmaceuticals, Inc. position peaked at $14K in Q2 2017.
  • 169 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2017.

Based on First Interstate Bank's 13F filing for Q3 2017, filed 8 Nov 2017.